🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Esther Frimpong

Florida Agricultural and Mechanical University

ORCID: 0000-0001-6908-823X

Materials ScienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer”.

Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer

BMC Cancer(2022)10.1186/s12885-022-10449-y

N/A

0DataRank · unranked

4 citations

Andriana Inkoom, Dexter Ebesoh, Raviteja Bulusu, Esther Frimpong, José G. Treviño +4 more

Application of modified gemcitabine-loaded solid lipid nanoparticle in the treatment of pancreatic cancer patient-derived xenograft model

Research Square(2022)10.21203/rs.3.rs-1777458/v1

N/A

0DataRank · unranked

2 citations

Nkafu Bechem Ndemazie, Taylor Smith, Esther Frimpong, Raviteja Bulusu, Rosemary A. Poku +5 more

Synthesis, characterization, and in vitro anticancer evaluation of 1,3-bistetrahydrofuran- 2yl-5-FU as a potential agent for pancreatic cancer

Research Square(2022)10.21203/rs.3.rs-1863111/v1

N/A

0DataRank · unranked

0 citations

Andriana Inkoom, Dexter Ebesoh, Raviteja Bulusu, Esther Frimpong, Jose Trevino +4 more

Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer

BMC Cancer(2023)10.1186/s12885-023-10928-w

N/A

0DataRank · unranked

17 citations

Nkafu Bechem Ndemazie, Taylor Smith, Esther Frimpong, Raviteja Bulusu, Rosemary A. Poku +5 more

Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer

International Journal of Molecular Sciences(2023)10.3390/ijms24054288

N/A

0DataRank · unranked

8 citations

Raviteja Bulusu, Xue Y. Zhu, Esther Frimpong, Andriana Inkoom, Joy Okoro +5 more

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

Journal of the National Medical Association(2023)10.1016/j.jnma.2023.01.008

N/A

0DataRank · unranked

5 citations

David L. DeRemer, Esther Frimpong, Edward Agyare, John M. Allen, Luisel Ricks‐Santi +4 more

Development of Novel Pyrimidine Nucleosides as Potential Anticancer Agents: Synthesis, Characterization, and Invitro Evaluation against pancreatic cancer

Research Square(2023)10.21203/rs.3.rs-3706035/v1

N/A

0DataRank · unranked

0 citations

Raviteja Bulusu, Joy Okoro, Andriana Inkoom, Nkafu Bechem Ndemazie, Sherise C. Rogers +4 more

Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer

European Journal of Pharmaceutical Sciences(2024)10.1016/j.ejps.2024.106754

N/A

0DataRank · unranked

9 citations

Raviteja Bulusu, Joy Okoro, Andriana Inkoom, Nkafu Bechem Ndemazie, Sherise C. Rogers +4 more

Sociodemographic characteristics associated with pancreatic cancer incidence and mortality among Blacks in the United States: a SEER-based study

American Journal of Cancer Research(2025)10.62347/gjcx1238

N/A

0DataRank · unranked

2 citations

Esther Frimpong